These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 27601557)
1. Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little. Hovingh GK; Kastelein JJ Circulation; 2016 Sep; 134(10):710-2. PubMed ID: 27601557 [No Abstract] [Full Text] [Related]
8. Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia. Canepa M; Artom N; Ameri P; Carbone F; Montecucco F; Ghigliotti G; Brunelli C; Dallegri F; Pende A; Pisciotta L Int J Cardiol; 2018 Mar; 255():215-220. PubMed ID: 29290422 [No Abstract] [Full Text] [Related]
9. [Protective effects of pravastatin against atherosclerosis in children with familial hypercholesterolemia]. Riesen WF Rev Med Suisse; 2005 Mar; 1(9):649. PubMed ID: 15813344 [No Abstract] [Full Text] [Related]
10. Optimal Treatment using Statins from Childhood in Heterozygous Familial Hypercholesterolemia. Nohara A J Atheroscler Thromb; 2016; 23(1):39-43. PubMed ID: 26370454 [No Abstract] [Full Text] [Related]
11. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia. Miltiadous G; Saougos V; Cariolou M; Elisaf MS Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279 [TBL] [Abstract][Full Text] [Related]
13. INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia. Sullivan DR; Hamilton-Craig I; van Bockxmeer F; Watts GF; Heart Lung Circ; 2012 Mar; 21(3):159-62. PubMed ID: 22364837 [No Abstract] [Full Text] [Related]
14. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615 [No Abstract] [Full Text] [Related]
15. Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin. Ryu SK; Hutten BA; Vissers MN; Wiegman A; Kastelein JJ; Tsimikas S J Clin Lipidol; 2011; 5(1):50-6. PubMed ID: 21262507 [TBL] [Abstract][Full Text] [Related]
16. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe. Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996 [No Abstract] [Full Text] [Related]
17. The cards I was dealt: my life with familial hypercholesterolemia. Ames M Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):218-9. PubMed ID: 25737486 [No Abstract] [Full Text] [Related]
18. Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy. Natsui H; Konishi T; Saiin K; Tamaki Y; Sato T; Takenaka S; Tada A; Mizuguchi Y; Kobayashi Y; Sato T; Kamada R; Kamiya K; Nagai T; Tanaka S; Anzai T Cardiol J; 2022; 29(2):362-363. PubMed ID: 35411933 [No Abstract] [Full Text] [Related]
19. Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia. Bos S; Duvekot MH; Touw-Blommesteijn AC; Verhoeven AJ; Mulder MT; Watts GF; Sijbrands EJ; Roeters van Lennep JE Atherosclerosis; 2015 Sep; 242(1):226-9. PubMed ID: 26222903 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of familial hypercholesterolemia: The impact of recent guidelines. Palma L; Welding M; OʼShea J Nurse Pract; 2016 Aug; 41(8):36-43. PubMed ID: 27414814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]